BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26763028)

  • 1. Magnetic resonance imaging-based endovascular versus medical stroke treatment for symptom onset up to 12 h.
    Wouters A; Lemmens R; Christensen S; Wilms G; Dupont P; Mlynash M; Schneider A; Laage R; Cereda CW; Lansberg MG; Albers GW; Thijs V;
    Int J Stroke; 2016 Jan; 11(1):127-33. PubMed ID: 26763028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion.
    Wheeler HM; Mlynash M; Inoue M; Tipirnini A; Liggins J; Bammer R; Lansberg MG; Kemp S; Zaharchuk G; Straka M; Albers GW;
    Int J Stroke; 2015 Jul; 10(5):723-9. PubMed ID: 25580662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic outcome of endovascular stroke therapy correlated with MR findings, infarct growth, and clinical outcome in the DEFUSE 2 trial.
    Marks MP; Lansberg MG; Mlynash M; Kemp S; McTaggart RA; Zaharchuk G; Bammer R; Albers GW;
    Int J Stroke; 2014 Oct; 9(7):860-5. PubMed ID: 24684804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular treatment for acute ischemic stroke beyond the 24-h time window: Selection by target mismatch profile.
    Nguyen TQ; Tran MH; Phung HN; Nguyen KV; Tran HTM; Walter S; Hoang DCB; Pham BN; Truong ALT; Tran VT; Nguyen TN; Pham AL; Nguyen HT
    Int J Stroke; 2024 Mar; 19(3):305-313. PubMed ID: 37807200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.
    Lansberg MG; Straka M; Kemp S; Mlynash M; Wechsler LR; Jovin TG; Wilder MJ; Lutsep HL; Czartoski TJ; Bernstein RA; Chang CW; Warach S; Fazekas F; Inoue M; Tipirneni A; Hamilton SA; Zaharchuk G; Marks MP; Bammer R; Albers GW;
    Lancet Neurol; 2012 Oct; 11(10):860-7. PubMed ID: 22954705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Target Mismatch Profile >24 Hours After Stroke Onset in DEFUSE 3.
    Christensen S; Mlynash M; Kemp S; Yennu A; Heit JJ; Marks MP; Lansberg MG; Albers GW
    Stroke; 2019 Mar; 50(3):754-757. PubMed ID: 30735466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).
    Albers GW; Lansberg MG; Kemp S; Tsai JP; Lavori P; Christensen S; Mlynash M; Kim S; Hamilton S; Yeatts SD; Palesch Y; Bammer R; Broderick J; Marks MP
    Int J Stroke; 2017 Oct; 12(8):896-905. PubMed ID: 28946832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial.
    Sarraj A; Mlynash M; Savitz SI; Heit JJ; Lansberg MG; Marks MP; Albers GW
    JAMA Neurol; 2019 Jun; 76(6):682-689. PubMed ID: 30734042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.
    Lansberg MG; Mlynash M; Hamilton S; Yeatts SD; Christensen S; Kemp S; Lavori PW; Ortega-Gutierrez S; Broderick J; Heit J; Marks MP; Albers GW;
    JAMA Neurol; 2019 Apr; 76(4):447-453. PubMed ID: 30688974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue.
    Lansberg MG; Cereda CW; Mlynash M; Mishra NK; Inoue M; Kemp S; Christensen S; Straka M; Zaharchuk G; Marks MP; Bammer R; Albers GW;
    Neurology; 2015 Aug; 85(8):708-14. PubMed ID: 26224727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion Imaging Mismatch Profiles in the Early Thrombectomy Window: A Single-Center Analysis.
    Schwarz G; Agostoni EC; Saliou G; Hajdu SD; Salerno A; Dunet V; Michel P; Strambo D
    Stroke; 2023 May; 54(5):1182-1191. PubMed ID: 37026456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods.
    Jovin TG; Saver JL; Ribo M; Pereira V; Furlan A; Bonafe A; Baxter B; Gupta R; Lopes D; Jansen O; Smith W; Gress D; Hetts S; Lewis RJ; Shields R; Berry SM; Graves TL; Malisch T; Rai A; Sheth KN; Liebeskind DS; Nogueira RG
    Int J Stroke; 2017 Aug; 12(6):641-652. PubMed ID: 28569123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular Stroke Treatment Outcomes After Patient Selection Based on Magnetic Resonance Imaging and Clinical Criteria.
    Leslie-Mazwi TM; Hirsch JA; Falcone GJ; Schaefer PW; Lev MH; Rabinov JD; Rost NS; Schwamm L; González RG
    JAMA Neurol; 2016 Jan; 73(1):43-9. PubMed ID: 26524074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximal Admission Core Lesion Compatible With Favorable Outcome in Acute Stroke Patients Undergoing Endovascular Procedures.
    Ribo M; Tomasello A; Lemus M; Rubiera M; Vert C; Flores A; Coscojuela P; Pagola J; Rodriguez-Luna D; Bonet S; Muchada M; Rovira A; Molina CA
    Stroke; 2015 Oct; 46(10):2849-52. PubMed ID: 26294674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of Volume and Signal Intensity on Fluid-attenuated Inversion Recovery MR Images after Endovascular Stroke Therapy.
    Federau C; Mlynash M; Christensen S; Zaharchuk G; Cha B; Lansberg MG; Wintermark M; Albers GW
    Radiology; 2016 Jul; 280(1):184-92. PubMed ID: 26761721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pittsburgh outcomes after stroke thrombectomy score predicts outcomes after endovascular therapy for anterior circulation large vessel occlusions.
    Rangaraju S; Liggins JT; Aghaebrahim A; Streib C; Sun CH; Gupta R; Nogueira R; Frankel M; Mlynash M; Lansberg M; Albers G; Jadhav A; Jovin TG
    Stroke; 2014 Aug; 45(8):2298-304. PubMed ID: 25005445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications.
    Turk AS; Nyberg EM; Chaudry MI; Turner RD; Magarik JA; Nicholas JS; Holmstedt CA; Chalela JA; Hays A; Lazaridis C; Chimowitz MI; Turan TN; Adams RJ; Jauch EC
    J Neurointerv Surg; 2013 Nov; 5(6):518-22. PubMed ID: 22935349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large Volumes of Critically Hypoperfused Penumbral Tissue Do Not Preclude Good Outcomes After Complete Endovascular Reperfusion: Redefining Malignant Profile.
    Nogueira RG; Haussen DC; Dehkharghani S; Rebello LC; Lima A; Bowen M; Belagaje S; Anderson A; Frankel M
    Stroke; 2016 Jan; 47(1):94-8. PubMed ID: 26604248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential responders.
    Ducroux C; Khoury N; Lecler A; Blanc R; Chetrit A; Redjem H; Ciccio G; Smajda S; Escalard S; Desilles JP; Mazighi M; Ben Maacha M; Piotin M; Fahed R
    Eur J Neurol; 2018 Aug; 25(8):1093-1099. PubMed ID: 29667266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.